These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 20034563

  • 1. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects.
    Tahara K, Yamamoto H, Hirashima N, Kawashima Y.
    Eur J Pharm Biopharm; 2010 Mar; 74(3):421-6. PubMed ID: 20034563
    [Abstract] [Full Text] [Related]

  • 2. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
    Zeng P, Xu Y, Zeng C, Ren H, Peng M.
    Int J Pharm; 2011 Aug 30; 415(1-2):259-66. PubMed ID: 21645597
    [Abstract] [Full Text] [Related]

  • 3. Oral nuclear factor-κB decoy oligonucleotides delivery system with chitosan modified poly(D,L-lactide-co-glycolide) nanospheres for inflammatory bowel disease.
    Tahara K, Samura S, Tsuji K, Yamamoto H, Tsukada Y, Bando Y, Tsujimoto H, Morishita R, Kawashima Y.
    Biomaterials; 2011 Jan 30; 32(3):870-8. PubMed ID: 20934748
    [Abstract] [Full Text] [Related]

  • 4. Improvements in transfection efficiency with chitosan modified poly(DL-lactide-co-glycolide) nanospheres prepared by the emulsion solvent diffusion method, for gene delivery.
    Tahara K, Sakai T, Yamamoto H, Takeuchi H, Hirashima N, Kawashima Y.
    Chem Pharm Bull (Tokyo); 2011 Jan 30; 59(3):298-301. PubMed ID: 21372409
    [Abstract] [Full Text] [Related]

  • 5. Hybrid-modified poly(D,L-lactide-co-glycolide) nanospheres for a novel cellular drug delivery system.
    Tahara K, Furukawa S, Yamamoto H, Kawashima Y.
    Int J Pharm; 2010 Jun 15; 392(1-2):311-3. PubMed ID: 20347023
    [Abstract] [Full Text] [Related]

  • 6. Cellular uptake mechanisms and intracellular distributions of polysorbate 80-modified poly (D,L-lactide-co-glycolide) nanospheres for gene delivery.
    Tahara K, Yamamoto H, Kawashima Y.
    Eur J Pharm Biopharm; 2010 Jun 15; 75(2):218-24. PubMed ID: 20332026
    [Abstract] [Full Text] [Related]

  • 7. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells.
    Tahara K, Sakai T, Yamamoto H, Takeuchi H, Hirashima N, Kawashima Y.
    Int J Pharm; 2009 Dec 01; 382(1-2):198-204. PubMed ID: 19646519
    [Abstract] [Full Text] [Related]

  • 8. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
    Dyawanapelly S, Koli U, Dharamdasani V, Jain R, Dandekar P.
    Drug Deliv Transl Res; 2016 Aug 01; 6(4):365-79. PubMed ID: 27106502
    [Abstract] [Full Text] [Related]

  • 9. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.
    Guan XP, Quan DP, Liao KR, Tao Wang, Peng Xiang, Mai KC.
    J Biomater Appl; 2008 Jan 01; 22(4):353-71. PubMed ID: 17494965
    [Abstract] [Full Text] [Related]

  • 10. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.
    Wang M, Zhang Y, Feng J, Gu T, Dong Q, Yang X, Sun Y, Wu Y, Chen Y, Kong W.
    Int J Nanomedicine; 2013 Jan 01; 8():1141-54. PubMed ID: 23658482
    [Abstract] [Full Text] [Related]

  • 11. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery.
    Yuan X, Shah BA, Kotadia NK, Li J, Gu H, Wu Z.
    Pharm Res; 2010 Jul 01; 27(7):1285-95. PubMed ID: 20309616
    [Abstract] [Full Text] [Related]

  • 12. Polymeric nanoparticles for siRNA delivery and gene silencing.
    Patil Y, Panyam J.
    Int J Pharm; 2009 Feb 09; 367(1-2):195-203. PubMed ID: 18940242
    [Abstract] [Full Text] [Related]

  • 13. Intracellular drug delivery using polysorbate 80-modified poly(D,L-lactide-co-glycolide) nanospheres to glioblastoma cells.
    Tahara K, Kato Y, Yamamoto H, Kreuter J, Kawashima Y.
    J Microencapsul; 2011 Feb 09; 28(1):29-36. PubMed ID: 21171814
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
    Chen H, Xie LQ, Qin J, Jia Y, Cai X, Nan W, Yang W, Lv F, Zhang QQ.
    Colloids Surf B Biointerfaces; 2016 Feb 01; 138():1-9. PubMed ID: 26638176
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Preparation and characterization of cationic PLGA nanospheres as DNA carriers.
    Ravi Kumar MN, Bakowsky U, Lehr CM.
    Biomaterials; 2004 May 01; 25(10):1771-7. PubMed ID: 14738840
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.